The most common adverse effect of EGFR inhibitors, found in more than 90% of patients, is a papulopustular rash that spreads across the face and torso; the rash's presence is correlated with the drug's antitumor effect.[33] In 10% to 15% of patients the effects can be serious and require treatment.[34][35]